Effect of hyperbaric oxygen on BDNF-release and... (2017 study) Skip to main content
Clinical Study PloS one 2017

Effect of hyperbaric oxygen on BDNF-release and neuroprotection: Investigations with human mesenchymal stem cells and genetically modified NIH3T3 fibroblasts as putative cell therapeutics.

Schulze J, Kaiser O, Paasche G, Lamm H, Pich A, Hoffmann A, et al., PloS one, 2017

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The researchers exposed lab-grown cells to repeated sessions of 100% oxygen at raised pressure to see how the cells grew and what they released.

What They Found

In this laboratory study using cultured cells, hyperbaric oxygen increased the growth of two fibroblast cell lines, while the number of human mesenchymal stem cells was lower after treatment at 2.0 bar. Both the genetically modified NIH3T3/BDNF fibroblasts and the native NIH3T3 fibroblasts showed highly significant increased growth after five days of treatment compared with normoxic controls. Cells were exposed 3 to 10 times to 100% oxygen at different pressures. Spiral ganglion neuron cultures grown in fluid from the fibroblasts and stem cells showed significantly higher survival, and hyperbaric oxygen treatment did not change this effect, up or down. The treatment also altered the pattern of proteins made by the stem cells.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The study used cultured cells rather than patients, and the abstract reports that stem cell numbers fell at 2.0 bar and that treatment altered stem cell proteins, so the results cannot be applied directly to people.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Neurological
Source Pubmed
PubMed ID 28542481
Year Published 2017
Journal PloS one
MeSH Terms Animals; Brain-Derived Neurotrophic Factor; Cell Proliferation; Cell Survival; Cell- and Tissue-Based Therapy; Culture Media, Conditioned; Female; Gene Expression Profiling; Humans; Hyperbaric Oxygenation; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; NIH 3T3 Cells

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology